Cargando…
Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer
BACKGROUND: Radiotherapy (RT) is used as monotherapy in poor performance patients with unresected locally advanced non-small cell lung cancer (LA-NSCLC), but their outcomes are not well-described. As novel therapies are increasingly considered in this space, it is important to understand contemporar...
Autores principales: | Gouran-Savadkoohi, Mohammad, Mesci, Aruz, Pond, Gregory R., Swaminath, Anand, Quan, Kimmen, Wright, Jim, Tsakiridis, Theodoros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992560/ https://www.ncbi.nlm.nih.gov/pubmed/36910062 http://dx.doi.org/10.21037/jtd-22-925 |
Ejemplares similares
-
(18)F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer
por: Mesci, Aruz, et al.
Publicado: (2023) -
The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada
por: Beers, Craig A., et al.
Publicado: (2023) -
Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
por: Nguyen, Eric K., et al.
Publicado: (2021) -
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance
por: Ahmadi, Elham, et al.
Publicado: (2023) -
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
por: Ali, Amr, et al.
Publicado: (2023)